KR910000130A - 진경제 - Google Patents

진경제 Download PDF

Info

Publication number
KR910000130A
KR910000130A KR1019890018293A KR890018293A KR910000130A KR 910000130 A KR910000130 A KR 910000130A KR 1019890018293 A KR1019890018293 A KR 1019890018293A KR 890018293 A KR890018293 A KR 890018293A KR 910000130 A KR910000130 A KR 910000130A
Authority
KR
South Korea
Prior art keywords
creosote
phenol
phenol derivative
component
antifungal composition
Prior art date
Application number
KR1019890018293A
Other languages
English (en)
Inventor
다쓰야 바바
노리오 오가따
Original Assignee
시바따 히또시
다이꼬 야꾸힝 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 시바따 히또시, 다이꼬 야꾸힝 가부시끼가이샤 filed Critical 시바따 히또시
Publication of KR910000130A publication Critical patent/KR910000130A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A61K35/04—Tars; Bitumens; Mineral oils; Ammonium bituminosulfonate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

내용 없음

Description

진경제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (6)

  1. 활성 성분으로서 크레오소오트 또는 그의 성분 페놀 유도체 또는 유도체들을, 약제학적으로 허용되는 담체와 결합하여 함유하는 진경 조성물.
  2. 제1항에 있어서, 상기 페놀 유도체가 구아이아콜, 크레오솔, 페놀, 크실레놀 또는 크레솔인 진경 조성물.
  3. 환자에세 크레오소오트 또는 그의 성분 페놀 유도체 또는 유도체들의 진경 유효량을 투여함을 특징으로 하는 그러한 치료를 요구하는 환자에서의 경축 치료방법.
  4. 제 3항에 있어서, 상기 페놀 유로체가 구아이아콜, 크레오솔, 페놀, 크레솔인 방법.
  5. 진경제로서 크레오소오트 또는 그의 성분 페놀 유도체.
  6. 진경 조성물의 제조를 위한 크레오소오트 또는 그의 성분 페놀 유도체의 용도.
    ※참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019890018293A 1989-06-01 1989-12-11 진경제 KR910000130A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP14082089 1989-06-01
JP89-140820 1989-06-01
JP1247781A JPH0625056B2 (ja) 1989-06-01 1989-09-21 鎮痙剤
JP89-247781 1989-09-21

Publications (1)

Publication Number Publication Date
KR910000130A true KR910000130A (ko) 1991-01-29

Family

ID=26473230

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890018293A KR910000130A (ko) 1989-06-01 1989-12-11 진경제

Country Status (8)

Country Link
US (1) US5112872A (ko)
EP (1) EP0400219B1 (ko)
JP (1) JPH0625056B2 (ko)
KR (1) KR910000130A (ko)
CA (1) CA2005072C (ko)
DE (1) DE68910676T2 (ko)
HK (1) HK2194A (ko)
PH (1) PH27336A (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210147632A (ko) * 2020-05-29 2021-12-07 동성제약주식회사 안전성이 확보된 소화기계 질환 예방 또는 치료를 위한 경구투여용 약학 조성물

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2545321B2 (ja) * 1992-08-21 1996-10-16 大幸薬品株式会社 平滑筋収縮抑制剤
GB9308469D0 (en) * 1993-04-23 1993-06-09 Wright George H Management of cholelithiasis
JP3074519B2 (ja) * 1996-07-01 2000-08-07 大幸薬品株式会社 腸液吸収促進剤
JP2006192922A (ja) * 2005-01-11 2006-07-27 Shigeru Co Ltd 車両用内装品における装着凹部の形成方法
US20060287347A1 (en) * 2005-06-21 2006-12-21 Aberg A K G Methods for treating smooth muscle disorders using trospium
US7390816B2 (en) * 2005-06-21 2008-06-24 Bridge Pharma, Inc. Methods for treating urinary incontinence in patients suffering from memory disorders
US20070004766A1 (en) * 2005-07-01 2007-01-04 Aberg A K G Methods for relaxation of smooth muscle contractions using Trospium
CA2868383C (en) * 2012-03-28 2019-12-31 Taiko Pharmaceutical Co., Ltd. Drug composition and soft capsule drug sealing the drug composition
CA3129648A1 (en) 2019-02-15 2020-08-20 Saol International Limited Injectable formulations comprising phenol and cyclodextrin and uses thereof________________________________

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4608258A (en) * 1983-08-17 1986-08-26 Taiko Pharmaceutical Co., Ltd. Medicament for treatment of diarrhea
JPS62142132A (ja) * 1985-12-16 1987-06-25 Tanpei Seiyaku Kk 新規包接化合物

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210147632A (ko) * 2020-05-29 2021-12-07 동성제약주식회사 안전성이 확보된 소화기계 질환 예방 또는 치료를 위한 경구투여용 약학 조성물

Also Published As

Publication number Publication date
JPH0386817A (ja) 1991-04-11
JPH0625056B2 (ja) 1994-04-06
EP0400219B1 (en) 1993-11-10
US5112872A (en) 1992-05-12
EP0400219A2 (en) 1990-12-05
CA2005072C (en) 1994-12-06
PH27336A (en) 1993-06-08
EP0400219A3 (en) 1991-01-16
HK2194A (en) 1994-01-14
DE68910676D1 (de) 1993-12-16
DE68910676T2 (de) 1994-05-26

Similar Documents

Publication Publication Date Title
KR910005880A (ko) 인플루엔자 비루스감염예방 및 치료제
KR890011590A (ko) 안지오스타틴
ES2053882T3 (es) Metodo para reducir la irritacion de la piel asociado con composiciones potenciadoras de penetracion del farmaco.
KR890000101A (ko) 반월조직의 치료 개선방법 및 치료약제
KR950002785A (ko) 골량을 증가시키기 위한 부갑상선 호르몬 및 랄옥시펜
KR870005637A (ko) 약물 데포
KR910004187A (ko) 세트랄린을 사용한 조기사정의 치료방법
KR910019640A (ko) 클로스트리듐 디피실레 하리증 및 위막성 대장염의 예방 및 치료용 의약조성물
KR910000130A (ko) 진경제
EP0045617A3 (en) Pharmaceutical composition
KR870008886A (ko) 2-알콕시-n-(1-아자바이사이클로 [2,2,2] 옥트-3-일)벤즈아미드 및 티오벤즈아미드
EP0535237A4 (en) Composition for relieving skin irritation and external preparation for percutaneous adminstration containing the same
KR930003913A (ko) 덱스트로메토르판의 진해효과를 증진시키기 위한 방법 및 약제학적 조성물
KR910004188A (ko) 세트랄린을 사용한 화학약품 의존성의 치료방법
KR900017599A (ko) 종양 치료용 약학 조성물
KR910004186A (ko) 제약학적 배합물
KR870011135A (ko) 시스-6-(4-아세트아닐리도)-8,9-디메톡시-2-메틸-1,2,3,4,4a,10b- 헥사이드로-벤조〔c〕〔1,6〕 나프티리딘으로 구성된 약학적 조성물 및 그것의 용도
DK0388732T3 (da) Pentasubstituerede phenyler
KR920019349A (ko) 불안을 치료하기 위한 r(+)-3-아미노-1-하이드록시-피롤리딘-2-온의 용도
KR900701322A (ko) 포도필린과 재조합 DNA인간 α인터페론의 배합물로 생식기 우췌를 치료하는 방법
CO5031290A1 (es) Formulacion lo
KR900012622A (ko) 피부질환치료 조성물
KR880000094A (ko) 위염치료제
KR920702623A (ko) 진해제
KR880013556A (ko) 도파민수용체 효능제의 용도

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application